Harmony Biosciences Holdings Inc

+0.05 (+0.12%)
Other Pre-Announcement

Harmony Biosciences Holdings Posts Q4 GAAP Earnings Per Share $0.00

Published: 03/25/2021 13:01 GMT
Harmony Biosciences Holdings Inc (HRMY) - Harmony Biosciences Reports Fourth Quarter and Full-year 2020 Financial Results and Business Updates.
Q4 GAAP Earnings per Share $0.00.
Q4 Revenue $160 Million.
Q4 Revenue Estimate $51.9 Million -- Refinitiv Ibes Data (analyst estimates).
Q4 Earnings per Share Estimate $0.09 -- Refinitiv Ibes Data (analyst estimates).
On Track to Initiate Two Additional Clinical Trials With Pitolisant in 2021.
As of Dec.
31, 2020, Co Had Cash and Cash Equivalents of $228.6 Million Compared to $24.5 Million for Same Period in 2019.
For Three-month Period Ended Dec.
31, 2020, Co Reported Net Loss of $0.2 Million, Or $0.00 per Diluted Share.